BDP8900
BDP8900 is a potent and selective inhibitor of myotonic dystrophy-related Cdc42-binding kinases (MRCKα and MRCKβ). BDP8900 reduces substrate phosphorylation, leading to morphological changes, motility inhibition and invasiveness of cancer cells.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2226507-05-5
- Fòrmula: C19H23N5S
- Peso molecular:353.48
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
|
MRCKα |
MRCKβ |
Chemical Information
-
No. CAS 2226507-05-5
-
Peso molecular 353.48
-
Fòrmula C19H23N5S
-
SMILES
N1(C2=CC=NC3=C2C(C4=NC=CS4)=CN3)C[C@]5(CCCCN5)CCC1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
BDP8900 Related Classifications
HY-111423 Related Classifications
Powered by Bioz